Viviane Hess

Mucinous Epithelial Ovarian Cancer: A Separate Entity Requiring Specific Treatment

Viviane Hess, Roger A’Hern, Nazar Nasiri et al. · Journal of Clinical Oncology · 2004 · 334 citations · Full text

Medicine, Gynecology, Oncology +16

CA 19-9 tumour-marker response to chemotherapy in patients with advanced pancreatic cancer enrolled in a randomised controlled trial

Viviane Hess, Bengt Glimelius, Philipp Grawe et al. · The Lancet Oncology · 2008 · 238 citations

Medicine, Oncology, Chemotherapy +5

Bevacizumab continuation versus no continuation after first-line chemotherapy plus bevacizumab in patients with metastatic colorectal cancer: a randomized phase III non-inferiority trial (SAKK 41/06)

Dieter Koeberle, Daniel Betticher, Roger von Moos et al. · Annals of Oncology · 2015 · 141 citations · Full text

Medicine, Oncology, Pharmacology +10

Adding cetuximab to capecitabine plus oxaliplatin (XELOX) in first-line treatment of metastatic colorectal cancer: a randomized phase II trial of the Swiss Group for Clinical Cancer Research SAKK

Markus Borner, Dieter Koeberle, Roger von Moos et al. · Annals of Oncology · 2008 · 127 citations · Full text

Medicine, Oncology, Pharmacology +10

Neoadjuvant chemotherapy followed by chemoradiation and surgery with and without cetuximab in patients with resectable esophageal cancer: a randomized, open-label, phase III trial (SAKK 75/08)

Thomas Ruhstaller, Peter Thuss‐Patience, Stefanie Hayoz et al. · Annals of Oncology · 2018 · 108 citations · Full text

Medicine, Oncology, Surgery +17